Skip Navigation

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease

Guidance issued Guidance issued
 
IP Guidance Number: IPG222
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease.

Description:
 An overtube and implant delivery mechanism is endoscopically guided to the gastro-oesophageal junction. Suction is applied to pull a fold of the oesophageal wall into the overtube. Saline is injected into this fold to create a space within the submucosa, and one or more hydrogel prostheses are implanted. The prostheses absorb water and expand to create a fold in the oesophageal wall bulking the oesophagus and preventing gastro-oesophageal reflux.
Arrangements:

Other (see guidance)
Topic Area:

Digestive system
Surgical procedures
Specialty:

Gastro-enterology
Specialist advice has
been sought from:

Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

British Society of Gastroenterology
Date notified to NICE: 27 June 2003
Provisional Consultation Date: Winter/Spring 2007
Guidance Publication Date: 27 June 2007
Contact Details:
Project Manager
(for general enquiries or comments)		 Ben Doak
ip@nice.org.uk
Technical Lead
(for procedure specific enquiries or comments) 		Sally Hamilton
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance